# Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV

> **NCT03037151** · PHASE4 · UNKNOWN · sponsor: **The HIV Netherlands Australia Thailand Research Collaboration** · enrollment: 100 (actual)

## Conditions studied

- Compensated Cirrhosis

## Interventions

- **DRUG:** Grazaoprevir/Elbasavir
- **DRUG:** Grazaoprevir/Elbasavir/RBV

## Key facts

- **NCT ID:** NCT03037151
- **Lead sponsor:** The HIV Netherlands Australia Thailand Research Collaboration
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2020-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03037151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03037151, "Safety and Efficacy of Grazoprevir and Elbasvir for GT1ang GT6 With and Without HIV". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03037151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*